PNEUMOVAX 23 is a vaccine given to help prevent infections caused by certain types of germs or bacteria called pneumococcus (pronounced new-mo-kock-us). For more information, see Section 1.

In connection with the start of the phase 3 trials of PCV21, Sanofi has expanded its alliance with South Korea-based SK Bio, ...

Dominance of the pneumococcal vaccine category is a race between Merck ... Merck also sells an older shot called Pneumovax 23, which covers 23 serotypes but is based on an older polysaccharide ...

The pneumococcal polysaccharide vaccine (PPV) is currently recommended for older adults and high-risk subjects, including patients with chronic obstructive pulmonary disease (COPD) and asthma.

3 According to the World Health Organization, there are two classes of pneumococcal vaccines currently available, with one based on olysaccharides and the other based on polysaccharides conjugated to ...